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Abstract 
Background: There is growing interest to add mass drug administration (MDA) to the already existing malaria 
prevention strategies, such as indoor residual spraying (IRS). However, successful MDA and IRS requires high popula-
tion-wide coverage, emphasizing the importance of community acceptance. This study’s objectives were to identify 
community-level facilitators and barriers during the implementation of both MDA and IRS in communities with high 
malaria transmission intensity.
Methods: This was a qualitative study conducted in two sub-counties in Katakwi district. Kapujan sub-county 
residents received two rounds of IRS and MDA while Toroma sub-county residents received two rounds of IRS only. 
Key informant interviews and focus group discussions were conducted with key influential district and sub-county 
personnel and community members. Data were analysed using thematic analysis. Transcripts and interview notes 
from the in-depth interviews were analysed using a coding scheme developed from pre-defined topics together 
with themes emerging from the data. The Nvivo software program was used to aggregate the data by codes and to 
present study findings.
Results: Overall, 14 key informants were interviewed: 4 from Katakwi district and 5 each from Kapujan and Toroma 
sub-counties. Five focus group discussions were conducted: 4 with community members (men and women), 2 in 
each sub-county and one with medical staff of Toroma health centre IV. Important themes for consideration raised 
by the respondents include community sensitization, conducting implementation during the low activity dry season, 
involvement of government and local leadership, use of the competent locally composed team, community knowl-
edge of malaria effects and consequences, combining interventions and evidence of malaria reduction from inter-
ventions. Potential barriers such as spreading of misinformation regarding interventions, the strong unpleasant smell 
from Actellic and inadequate duration of engagement with the community should be taken into consideration.
Conclusion: This study documents important community engagement strategies that need to be considered when 
implementing malaria MDA in combination with IRS, for malaria prevention in such settings. This information is useful 
for malaria programmes, especially during the design and implementation of such community level interventions.
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Background
In Uganda, malaria is endemic in approximately 95% of 
the country and affects over 90% of the population. It 
is responsible for 30 to 50% of out-patient admissions, 
15 to 20% of in-patient admissions and 20% of hospital 
deaths [1]. Pregnant women and children under 5 years 
old are the most affected. Additionally, findings from the 
2014 Malaria Indicator Survey (MIS) estimate malaria 
prevalence among children under 5  years at 19% [2]. 
Malaria is therefore considered a disease of public health 
importance by the National Malaria Control Programme 
(NMCP) which has implemented a number of interven-
tions to reduce this burden, including the distribution 
of long-lasting insecticidal nets (LLINs), indoor residual 
spraying (IRS), intermittent preventive therapy (IPTp) 
in pregnant women, and malaria case diagnosis with 
prompt treatment [1].
However, there is evidence to suggest that vector con-
trol and malaria case management may not be adequate 
to control malaria and reduce transmission in all areas 
[3]. Consequently, there is growing interest in treat-
ing asymptomatic individuals to augment malaria con-
trol and reduce malaria transmission, and in targeting 
hotspots of malaria transmission to reduce the human 
infectious reservoir [4]. One of the treatment approaches 
considered is mass drug administration (MDA), oth-
ers are intermittent preventive therapy (IPT) and inter-
mittent screening and testing (IST) [4, 5]. MDA is the 
empiric administration of a therapeutic anti-malarial 
regimen to an entire population at the same time. The re-
emergence of MDA as a potential intervention especially 
for malaria elimination is because of the availability of 
safe, efficacious and long-acting artemisinin-based com-
bination therapy (ACT), such as dihydroartemisinin–
piperaquine (DP) [6–8]. Indeed, trials conducted in the 
other settings have shown MDA using DP to be suc-
cessful in reducing population parasite prevalence. For 
instance, in Cambodia, MDA given once, or in some 
cases repeated at day 42, to the entire population success-
fully reduced the parasite prevalence from 52.3 to 2.6% 
after 3 years [9].
The processes of carrying out an MDA programme 
are complex, especially in large communities. Evidence 
from other MDA studies of disease conditions such as 
lymphatic filariasis [10, 11] and schistosomiasis [12] have 
shown that community involvement is essential for the 
success of such campaigns. However, the high burden 
of malaria and the high transmission rates, coupled with 
multiple and sometimes complex treatment protocols 
[1], may require a different or robust community engage-
ment approach beyond what is already known or done 
for other disease conditions. This could be further com-
plicated when MDA is implemented in combination with 
other vector control strategies, such as IRS. The impor-
tance of high population coverage of such interventions 
is essential for their success, emphasizing the importance 
of community acceptance [13, 14]. A recent mathemati-
cal modelling publication by Brady et  al. demonstrated 
that the higher the effective coverage of an interven-
tion, the greater its impact [15]. Therefore, understand-
ing the community’s dynamics and perceptions is one of 
the important steps towards this goal. This study set out 
to identify community-level facilitators and barriers for 
the implementation of both MDA and IRS at community 
level.
Methods
Study design
This is a qualitative study that was conducted between 
April and June 2017 and reported according to the stand-
ards of reporting of qualitative research [16]. It is part 
of a larger quasi-experimental project conducted in 
Katakwi district, an area of high malaria transmission 
intensity. According to baseline malaria data obtained 
from the 2016 Health Management and Information Sys-
tem (HMIS), the three sub-counties reported 4037 lab-
oratory-confirmed malaria cases of the total tests done, 
which translated to a 30% positivity rate [17].
Summary description of the intervention 
quasi‑experimental study
This is an ongoing project that commenced in August 
2016 with the primary objective to investigate the impact 
of population-based MDA in combination with IRS on 
both clinical and entomological malaria indicators. It 
is conducted in three sub-counties of Katakwi district: 
Kapujan, Toroma and Magoro whose population esti-
mates are 14,468, 11,825 and 18,564, respectively. At 
baseline, all three sub-counties received LLINs as part 
of the 2013 and 2017 universal distribution campaigns, 
however, none received any IRS. This study intervention 
is MDA using DP, and IRS using Actellic, implemented 
as follows: Kapujan households and residents receive 
both IRS and MDA, Toroma households receive IRS 
only, while Magoro is the control sub-county and con-
tinues to receive the standard of care malaria prevention 
and treatment activities, such as universal distribution of 
LLINs, IPTp, diagnosis of malaria and prompt treatment 
with ACT [1]. Specific to the study, interventions are 
implemented at the same time following approximately 
a 6-monthly interval, with the first round conducted in 
December 2016. Before intervention implementation, 
community-wide information, education and commu-
nication (IEC) was conducted to raise awareness of the 
study. National and sub-national stakeholders, including 
the district and sub-county leadership, were engaged to 
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be part of the IEC team. Informed consent was sought 
from household heads before IRS implementation and all 
individuals eligible to take MDA. Specifically, for MDA, 
additional assent was sought from children between 8 
and 17  years before their guardian’s consent on their 
behalf. The guardians of children aged 6  months to 
7 years also consented on their behalf. To minimize con-
tamination among the sub-counties, the following was 
done: group-level interventions such as assigning the 
whole sub-county to intervention with all households 
(for IRS) and members (for MDA) eligible for interven-
tion; before the start of interventions, all households 
(using global position system for location and to demar-
cate sub-county boundaries) and household members 
were enumerated and households were assigned a unique 
ID placed on the household front door while members 
receiving MDA had a unique ID bar code placed on par-
ticipant’s exercise book; at the time of intervention, only 
households and members assigned a unique ID received 
intervention; all sub-county members were eligible to 
be sampled for measurement of effect of the interven-
tions. Preliminary results from the first round show that 
the coverage for MDA was 80.6% (13,353 out of 16,577 
individuals registered) while IRS coverage was estimated 
98.4% (11,662 out of total 11,851 structures found).
Study setting, population and sampling strategy
This qualitative study was conducted in Kapujan and 
Toroma sub-counties, for which intervention was imple-
mented. Participants for the key informant interviews 
(KII) were selected from various levels of the district 
administration, community and religious leadership after 
consultation with district and sub-county leaders and rel-
evant stakeholders. They were selected purposively based 
on their engagement with study personnel and virtue of 
their position in the district, which gave them insight on 
people’s experiences with the study interventions. They 
were first contacted by phone to inform them of the 
interviews and to set an interview time. Focus group dis-
cussions (FGDs) comprised both men and women from 
communities in the two sub-counties. One FGD was 
conducted with health facility staff of the largest health 
centre IV that covers both sub-counties. Sub-county and 
village leaders were contacted and asked to suggest mem-
bers to be included in the FGDs. Each focus group com-
prised 8–12 members.
Data collection tool and study procedures
Semi-structured KIIs and FGDs interview topic guides 
were developed and pre-tested for reliability. Topics cov-
ered included: malaria prevention and interventions in 
the community; conduct of MDA and/or IRS; practicality 
of implementation; and, adaptation and integration while 
probing for facilitators and barriers. Two trained and 
experienced personnel were involved during the inter-
view process, an interviewer and an assistant who took 
notes of the discussion. All interviews were also recorded 
using a digital voice recorder. Written informed consent 
was sought before and all interviews were conducted in a 
language that was most comfortable for the interviewee, 
either in English or Ateso, the locally spoken language. 
Summaries of the interviews were all written in the lan-
guage of the interview, and later translated into English. 
All these activities were supervised by two experienced 
IEC study team members and one qualified qualitative 
study expert with extensive experience in conducting 
such studies.
Data processing and analysis
Data were analysed using thematic analysis. Transcripts 
and interview notes from the in-depth interviews were 
analysed using a coding scheme developed from pre-
defined topics together with themes emerging from the 
data. Analysis was conducted independently by differ-
ent members of the study personnel on different tran-
scripts and then a final coding scheme was agreed on 
and applied to all transcripts, with at least two members 
of the study personnel reviewing each transcript. The 
reviewers went through the transcripts, discussing and 
agreeing how best to code the transcripts while reviewing 
the existing codes. The Nvivo software program was used 
to aggregate the data by codes and to assist with findings 
presentation.
Results
Characteristics of study participants
Fourteen key informants were interviewed: 4 from 
Katakwi district and 5 each from Kapujan and Toroma 
sub-counties (Table  1). Five FGDs were conducted: 4 
with community members (men and women), 2 in each 
sub-county and one with medical staff of Toroma health 
centre IV.
Emerging themes
Facilitators for intervention
There were 10 main facilitators to the intervention which 
included:
Informed consent for community leadership and members 
before intervention
All respondents (key informants and from FGDs) 
reported having consented for both IRS to be applied 
in their household and MDA for individuals after get-
ting adequate information regarding these interventions 
before they were implemented. Additionally, the district 
health officer and local council leaders also said that they 
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had been contacted to give consent for the interventions 
to be conducted in their areas.
“Before someone makes an informed consent, that 
person would have gotten information. They should 
point out the benefits, the pros and cons, the adverse 
effects so that even the lay man in the village will 
know” FGD health workers
Intervention conducted in the dry season
Two FGD respondents felt that the interventions had 
been implemented at the right time when the mosquitoes 
were many, the season was dry and people were harvest-
ing, which meant they were more available at home to be 
involved in study-related activities.
Community sensitization and mobilization of relevant 
stakeholders
Four influential key informants, including the district 
health officer, district secretary for health, two local 
council chairmen (levels III and V) and respondents of 
one FGD mentioned that sensitization and mobilization 
of all relevant stakeholders, including the community and 
the local leaders, for the interventions was being handled 
well by the study team.
“At the onset, there was mobilization and advis-
ing people on how the interventions were to be con-
ducted. So if people were not sensitized, this project 
would not have been a success. Because if you want 
to do anything, you must tell the person its advan-
tages and disadvantages so when people understand 
that, it is very easy for them to accept.” LC III chair-
man
For IRS specifically, the FGD respondents were happy 
that the community mobilizers went to their households 
ahead of the spraying team, telling people to move their 
belongings out of the houses before the spraying team 
arrived.
Technically competent and trusted implementation team
Respondents from all the FGDs and two key inform-
ants mentioned that they appreciated several attributes 
of the team that implemented the interventions, such as 
their friendly attitude, focus on their work, punctuality, 
approachable, knowledgeable and consideration:
“The team, they were knowledgeable on how they 
mixed the spray products and prescribed the drugs. 
I think they were mixing it in a correct way and 
they could tell you to cover your things before, which 
was a sign of being kind other than just working. In 
case there was some things which were big and you 
couldn’t carry out, they were helpful.” FGD respond-
ent
Local implementing team members
Respondents from two FGDs mentioned that having the 
implementing team members employed from the local 
area played a big role in successful interventions imple-
mentation, especially IRS:
“Since the spray operators were from within, they 
could even just ride bicycles or sometimes they could 
even go on foot. To us this was the best, our own 
community members were selected and as a result 
they worked with one heart because they knew what 
their community was going through as a result of the 
burden of malaria.” FGD medical staff respondent
Government involvement
All key informants and respondents from three FDGs 
believed that the implementing organization had sought 
permission from government to implement the interven-
tions and as such they felt confident to participate in the 
interventions. Also many of the respondents participated 
because they had confidence in the authenticity of the 
organization and its activities.
Involvement of local leadership
All the key informants and respondents from FGDs cited 
several community factors that supported the interven-
tions, such as local involvement of key influencers includ-
ing the local leaders. For example, the village health team 
members helped with follow-up of participants during 
the MDA exercise by visiting homes to ensure adherence.
Table 1 Key informant respondents
Key informant District 
level, N = 4
Sub‑county level
Kapujan, 
N = 5
Toroma, 
N = 5
District health officer 1 – –
Local council V chairman 1 – –
Malaria focal person 1 – –
Health secretary 1 – –
Local council III chairman – 1 1
Health centre IV in-charge – – 1
Manager private provider clinic – 1 –
Opinion leader – 1 1
Religious leader – 1 –
School head teacher – 1 1
Village health team – – 1
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“… the local leadership and government should take 
a step in educating its people because that is their 
role. Secondly religious leaders should also pass on 
this information. It is the responsibility of these lead-
ers to educate their people.” FGD community mem-
ber
Community knowledge of the cost of preventing and treating 
malaria
Six key informants and respondents from FGDs men-
tioned that they participated in the study because of 
the high expenses they incur preventing and treating 
malaria. The knowledge that the communities spend high 
expenses treating frequent malaria episodes was a moti-
vator for taking up IRS and MDA:
“I accepted because I used to spend a lot of money 
treating malaria. I personally often fell sick almost 
every 2 weeks. So when I heard about IRS I knew my 
problems would be solved.” FGD community mem-
ber
Evidence of reduced malaria burden after the intervention
All key informant interviewees and respondents from all 
FGDs mentioned that they had observed a drastic drop in 
malaria cases in the areas where intervention was being 
conducted. They also got study updates as part of the 
Community Advisory Board. Additionally, health-worker 
FGD respondents also observed a drastic drop in malaria 
cases especially those stationed at the out-patient depart-
ment (OPD), which prompted them to not only accept 
the interventions but also to encourage the community to 
take them up.
“When you actually see the attendance of the OPD 
register, malaria has reduced, basically possibly 
because of indoor residual spraying. It has reduced 
the workload of OPD, you find that patients are now 
very few.” Health facility health worker
Setting up centres to manage drug side effects
Respondents from three FGDs mentioned that putting in 
place a system of managing side effects at the local health 
facilities strengthens community confidence in the inter-
vention and encourages participation.
“In my opinion, I was of a view that if the organiza-
tion is well equipped, let there be nurses to attend to 
emergency cases that arise as a result of MDA. Let 
them be put in various health units to help us with 
such cases because in most cases the nurses who are 
in these health centres already have their work load 
and as a result, they tend to ignore us when we reach 
the units. One thing I know is that the drug cannot 
be brought knowing it can harm…” FGD community 
member
Combining IRS and MDA interventions for malaria 
prevention
The district malaria focal person, a religious leader and 
FGD respondents from the sub-county that was receiving 
IRS only suggested that instead of receiving one interven-
tion (IRS only), they should also be included among those 
receiving MDA because this would enhance malaria pre-
vention in their community, an important aspect for their 
continued engagement.
“Spraying alone can’t help so to me let all the three 
interventions be brought together, e.g. MDA, IRS and 
the mosquito nets. Right now, yes, our houses have 
been sprayed but when we sit outside sometimes 
mosquitoes still bite us before bed-time. So if there 
was medicine I am sure it would work best.” FGD 
community member
Challenges to intervention
Three challenges included:
Instances of community mis‑information that lead to the fear 
of taking up intervention
This was mentioned by respondents from four FGDs 
conducted in the areas that were receiving both interven-
tions. There were instances of mis-information regarding 
the intervention mainly from community individuals who 
did not understand the interventions or had opposing 
views to either MDA or IRS. Some of this mis-informa-
tion caused fear among community members that lead to 
a few refusing the intervention:
“I remember of the case where some people refused 
to take the drug. Something that actually happens 
and results in people being mislead. That these drugs 
can cause some effects for example they said that 
these drugs will make men fail to perform in bed. 
But then to some of us that was not the issue because 
we swallowed and there was no problem.” FGD com-
munity member
Household member inconvenience during IRS 
implementation
Respondents from the four FGDs conducted in the IRS 
sub-counties described the spraying exercise as cum-
bersome especially for households that possessed a lot 
of property in their homes. This is because the process 
required moving everything out of the house to allow for 
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the spray to be conducted. Additionally, some respond-
ents complained about the smell of Actellic after the 
spraying of their households.
“People were complaining about the smell of the 
drug that was used for spraying houses because it 
was causing uneasiness, others say it caused vomit-
ing, others said I got diarrhea yesterday because of 
the smell of the drug.” Key informant village health 
team member
Short time allocated for implementation of intervention
A few respondents from two FGDs felt that the time 
allocated for IRS and MDA was not enough with some 
community members observing that the implementation 
teams were in a hurry to complete the work.
Discussion
This study documents important facilitators and barriers 
to be considered for a successful community-wide imple-
mentation of both MDA and IRS for malaria preven-
tion in a high malaria transmission setting. For instance, 
community sensitization and mobilization campaigns 
were recognized as an important activity for a success-
ful intervention uptake. This finding is supported by 
similar studies conducted in The Gambia and Cambo-
dia which showed that such sensitizations are crucial 
for community adherence to MDA [18]. These are simi-
lar findings reported from MDA studies conducted for 
conditions such as lymphatic filariasis [10, 11]. In this 
study, a number of communication channels were used, 
including radio announcements and talk shows, village 
meetings and information posters. Information such as 
the description of interventions, their importance, fre-
quency of implementation, recipients, risks and benefits 
was included. This was further complimented by person-
to-person interactions before any interventions could 
be implemented, especially regarding informed consent 
procedures. This sensitization campaign could have been 
the most important strategy responsible for the observed 
high population coverage of this study [19–21]. Addition-
ally, the use of already existing health facility infrastruc-
ture and personnel as centres to manage any occurring 
MDA and IRS adverse events could have possibly pro-
vided additional confidence for the community to take up 
the intervention.
It was also noted that the more knowledgeable individ-
uals were about the effects and consequences of malaria, 
the more they were willing to take up MDA and IRS. This 
is because of the anticipated advantages these interven-
tions would bring to their families and communities [22–
24]. This finding lends support to the importance of IEC 
and behaviour change communication (BCC) prior to 
intervention implementation. This was further strength-
ened when community leadership and health workers 
observed evidence of reduced number of mosquitoes and 
clinical malaria burden in their communities following 
intervention implementation, which is a classic example 
of proof of intervention effectiveness. Furthermore, some 
residents especially in the IRS-only sub-county were 
advocating having MDA in their area, in addition to IRS, 
because this was known to work synergistically to reduce 
the malaria burden.
The importance of involving key government insti-
tutions, such as NMCP and sub-national levels during 
community-wide interventions was echoed by almost 
all of the key informants. Greater community assurance 
is attached to interventions for which the implement-
ing partners collaborate with the leadership [18, 22, 24]. 
In this study, this collaborative involvement with gov-
ernment institutions was not only at central level, but 
included district, sub-counties and village levels. Other 
important facilitators for improvement of community 
confidence included a trusted implementing partner who 
is known by the community to deliver significant inter-
ventions, and the use of a technically competent team 
mostly made up of local community members who are 
familiar with the population and setting [24].
The majority of community members appreciated the 
timing of the intervention during the dry harvesting sea-
son. This is traditionally a less busy working season for 
this mainly agricultural community because most house-
hold members are engaged in crop harvesting and were, 
therefore, available at home with time to be engaged in 
other activities. This is crucial, especially for the MDA 
intervention, which requires individual household mem-
bers to be present so as to take the medication. Indeed, 
there is evidence from another qualitative MDA study 
from The Gambia showing that conducting such exer-
cises, especially in rural settings, required a time/season 
when individuals were less engaged in their farmlands 
and available at home [17].
However, there were a few barriers that were men-
tioned by a few respondents that still warrant rec-
ognition so as to minimize and prevent them from 
worsening during such community campaigns. Such 
challenges included instances of community misconcep-
tions and mis-information by individuals who either do 
not understand the interventions or had opposing views. 
This sometimes led to fear among some community 
members who opted not to take up the interventions. 
Such instances have been reported in other studies con-
ducted in Asia and other African settings that showed 
the negative impact of community misconceptions on 
MDA acceptability [18, 25, 26]. Specific to IRS, the strong 
unpleasant smell of Actellic has been well documented 
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[27, 28] and there is the possibility that this could be a 
deterring issue for uptake of this intervention when using 
this compound. Finally, the duration of intervention 
implementation should be longer to allow the commu-
nity greater and adequate interaction with the implemen-
tation team. This would enhance community knowledge 
and acceptance of intervention.
There are study limitations that need to be acknowl-
edged, such as the small sample size which could be 
argued to affect the validity of these findings. There is also 
the possibility of researcher bias from the purposive sam-
pling design of the key informants, since their responses 
are personal impressions. However, both of these 
instances were minimized by triangulating information 
from two sources of data collection: key informant inter-
views and FGDs. Additionally, there was extensive con-
sultation undertaken to include important and influential 
personnel from the different levels of leadership for key 
informant interviews, while community village leaders 
were part of the selection of focus group members.
Conclusion
Community sensitization on interventions, including 
malaria-specific knowledge, implementing interventions 
during the low farm-related activity periods, involvement 
of government and local leadership during implementa-
tion, and the use of a competent implementation team 
are essential for a high population acceptance of both 
MDA and IRS in this community. Potential barriers, such 
as spreading of mis-information regarding interventions, 
the strong unpleasant smell from Actellic, and inadequate 
duration for engagement with the community should be 
taken into consideration to limit their negative impact. 
Even though most of these findings are similar to those 
from other MDA or IRS from other settings, this study 
adds to literature by documenting community engage-
ment strategies when implementing these interventions 
in combination, in such settings.
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